Regulatory Delays Will Curb Uptake But Will Allow Cautious Progress
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
10 Aug 25
Updated
10 Aug 25
AnalystLowTarget's Fair Value
US$41.00
7.7% undervalued intrinsic discount10 Aug
US$37.84
1Y
-33.4%7D
10.3%